An app full of Al helps the medicine go down

• Autores: Sally Adee
• Localización: New scientist, ISSN 0262-4079, Nº. 3071, 2016, pág. 24
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • The app, AiCure, is being used in US drug trials to ensure participants stick to the rules. It could also have a role to play in stopping the spread of antibiotic resistance, its creators say. The New York start-up that built AiCure has won $19.5 million in funding--nearly a third of which is government backing via the US National Institutes of Health--to address the problem of people not taking their medication properly. Some of these are individuals who enroll in multiple trials in order to make money. Researchers have blamed so-called "professional patients" for the rise in placebo effects in clinical trials of antidepressants, which have seen placebo response rates as high as 50%. Some estimate that professional patients now make up 1 in 20 trial participants.